DrugPatentWatch Database Preview

Drugs in Development Information for Dasotraline

« Back to Dashboard

Summary for Dasotraline

US Patents	16
International Patents	79
US Patent Applications	29
WIPO Patent Applications	6
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2017-03-31)
Vendors	8

US Patents for Dasotraline

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Dasotraline		Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide	Sepracor Inc. (Marlborough, MA)
Dasotraline		Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide	Sepracor Inc. (Marlborough, MA)
Dasotraline		Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine	Sepracor Inc. (Marlborough, MA)
Dasotraline		Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine	Sepracor Inc. (Marlborough, MA)
Dasotraline		Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine	Sepracor Inc. (Marlborough, MA)

International Patents for Dasotraline

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Dasotraline	Australia	2003272460	2022-09-16
Dasotraline	Brazil	0314377	2022-09-16
Dasotraline	Canada	2498152	2022-09-16
Dasotraline	China	100584818	2022-09-16
Dasotraline	China	101712626	2022-09-16